Published October 31, 2025 | Version v1
Journal article Open

CASO CLÍNICO: TIROIDITIS DE HASHIMOTO CON HIPOTIROIDISMO PROGRESIVO EN MUJER JOVEN

  • 1. Universidad Libre Seccional Cali, Programa de Medicina Cali; Valle del cauca, Colombia
  • 2. Universidad Santiago de Cali, Programa de Medicina Cali; Valle del cauca, Colombia.

Description

La tiroiditis de Hashimoto es la principal causa de hipotiroidismo adquirido en regiones con adecuado consumo de yodo y representa un modelo clásico de autoinmunidad órgano-específica. Se caracteriza por la presencia de autoanticuerpos antitiroideos, infiltrado linfocitario progresivo y destrucción del parénquima tiroideo, lo que conduce al desarrollo de hipotiroidismo clínico si no se identifica y trata de forma oportuna. Se presenta el caso de una mujer de 29 años, previamente sana, con antecedentes familiares de enfermedad autoinmune, que consultó por fatiga persistente, aumento de peso, plenitud cervical y síntomas inespecíficos como estreñimiento, piel seca y caída del cabello. Al examen físico se documentó bocio difuso, piel fría y bradicardia. Los estudios revelaron TSH elevada, T4 libre disminuida y anticuerpos antitiroideos positivos. La ecografía tiroidea mostró glándula aumentada, hipoecoica y heterogénea, mientras que la punción aspirativa confirmó hallazgos compatibles con tiroiditis de Hashimoto. Se inició tratamiento con levotiroxina, logrando mejoría clínica y normalización bioquímica tras 12 semanas. Este caso resalta la importancia de mantener un alto índice de sospecha clínica frente a síntomas inespecíficos en mujeres jóvenes, especialmente con antecedentes familiares de autoinmunidad. El diagnóstico precoz y la reposición hormonal permiten prevenir complicaciones metabólicas, cardiovasculares y reproductivas, favoreciendo la recuperación funcional y la calidad de vida.

Abstract (English)

Hashimoto’s thyroiditis is the leading cause of acquired hypothyroidism in regions with adequate iodine intake and represents a classical model of organ-specific autoimmunity. It is characterized by the presence of antithyroid autoantibodies, progressive lymphocytic infiltration, and destruction of the thyroid parenchyma, ultimately leading to clinical hypothyroidism if not identified and treated in a timely manner. We report the case of a 29-year-old woman, previously healthy, with a family history of autoimmune disease, who presented with persistent fatigue, weight gain, cervical fullness, and nonspecific symptoms such as constipation, dry skin, and hair loss. Physical examination revealed a diffuse, firm, painless goiter, cold skin, and bradycardia. Laboratory tests showed elevated TSH, decreased free T4, and positive antithyroid antibodies. Thyroid ultrasound demonstrated an enlarged, hypoechoic, heterogeneous gland, while fine-needle aspiration confirmed histological features consistent with Hashimoto’s thyroiditis. Levothyroxine therapy was initiated, leading to clinical improvement and biochemical normalization after 12 weeks. This case underscores the importance of maintaining a high index of clinical suspicion in young women with nonspecific constitutional symptoms, particularly in the context of a family history of autoimmunity. Early diagnosis and timely hormone replacement therapy are essential to prevent metabolic, cardiovascular, and reproductive complications, thereby improving functional recovery and quality of life.

Files

sanum_v9_n4_a12.pdf

Files (262.8 kB)

Name Size Download all
md5:8f41d75fb7d314027750ecd141b75e9b
262.8 kB Preview Download

Additional details

Additional titles

Translated title (English)
CLINICAL CASE: HASHIMOTO'S THYROIDITIS WITH PROGRESSIVE HYPOTHYROIDISM IN A YOUNG WOMAN

Identifiers

ISSN
2530-5468

Dates

Submitted
2025-08-25
Accepted
2025-10-02

Software

References

  • 1. Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol Arch Intern Med. 2022 Mar 30;132(3):16222. doi: 10.20452/pamw.16222. Epub 2022 Mar 3. PMID: 35243857; PMCID: PMC9478900. 2. Kaur J, Jialal I. Hashimoto Thyroiditis. [Updated 2025 Feb 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459262/ 3. Ralli M, Angeletti D, Fiore M, D'Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A. Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020 Oct;19(10):102649. doi: 10.1016/j.autrev.2020.102649. Epub 2020 Aug 15. PMID: 32805423. 4. Akamizu T, Amino N. Hashimoto's Thyroiditis. [Updated 2017 Jul 17]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK285557/ 5. Baretić M. 100 godina Hashimotova tireoiditisa, bolesti koja jos uvijek intrigira--prikaz bolesnice [100 years of Hashimoto thyroiditis, still an intriguing disease]. Acta Med Croatica. 2011 Dec;65(5):453-7. Croatian. PMID: 22994016. 6. Weetman AP. The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. Eur Thyroid J. 2013 Jan;1(4):243-50. doi: 10.1159/000343834. Epub 2012 Nov 2. PMID: 24783026; PMCID: PMC3821488. 7. Vargas-Uricoechea H, Castellanos-Pinedo A, Urrego-Noguera K, Pinzón-Fernández MV, Meza-Cabrera IA, Vargas-Sierra H. A Scoping Review on the Prevalence of Hashimoto's Thyroiditis and the Possible Associated Factors. Med Sci (Basel). 2025 Apr 10;13(2):43. doi: 10.3390/medsci13020043. PMID: 40265390; PMCID: PMC12015930. 8. Sohrab M, Kashi Z, Bahar A. Hashimoto's thyroiditis presenting as a single toxic adenoma (A case report). Caspian J Intern Med. 2020 Fall;11(4):450-453. doi: 10.22088/cjim.11.4.450. PMID: 33680390; PMCID: PMC7911775. 9. Tripolino O, Mirabelli M, Misiti R, Torchia A, Casella D, Dragone F, Chiefari E, Greco M, Brunetti A, Foti DP. Circulating Autoantibodies in Adults with Hashimoto's Thyroiditis: New Insights from a Single-Center, Cross-Sectional Study. Diagnostics (Basel). 2024 Oct 31;14(21):2450. doi: 10.3390/diagnostics14212450. PMID: 39518417; PMCID: PMC11544974.